Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cytokinetics (CYTK) Debt Ratio (2016 - 2025)

Cytokinetics (CYTK) has disclosed Debt Ratio for 14 consecutive years, with 0.2 as the latest value for Q4 2025.

  • On a quarterly basis, Debt Ratio changed N/A to 0.2 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.2, a N/A change, with the full-year FY2025 number at 0.2, changed N/A from a year prior.
  • Debt Ratio was 0.2 for Q4 2025 at Cytokinetics, up from 0.12 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.2 in Q4 2025 to a low of 0.06 in Q4 2021.
  • A 5-year average of 0.09 and a median of 0.08 in 2023 define the central range for Debt Ratio.
  • Peak YoY movement for Debt Ratio: plummeted 54.4% in 2021, then skyrocketed 110.47% in 2025.
  • Cytokinetics' Debt Ratio stood at 0.06 in 2021, then grew by 13.36% to 0.06 in 2022, then increased by 10.97% to 0.07 in 2023, then rose by 3.74% to 0.07 in 2024, then soared by 174.73% to 0.2 in 2025.
  • Per Business Quant, the three most recent readings for CYTK's Debt Ratio are 0.2 (Q4 2025), 0.12 (Q3 2025), and 0.14 (Q2 2025).